Leflunomide for polyomavirus type BK nephropathy.
Williams
James W
JW
Javaid
Basit
B
Kadambi
Predeep V
PV
Gillen
Daniel
D
Harland
Robert
R
Thistlewaite
J Richard
JR
Garfinkel
Marc
M
Foster
Preston
P
Atwood
Walter
W
Millis
J Michael
JM
Meehan
Shane M
SM
Josephson
Michelle A
MA
D000814:Aniline Compounds / Q000097:blood; D000998:Antiviral Agents / Q000378:metabolism / Q000627:therapeutic use*; D001739:BK Virus / Q000187:drug effects / Q000302:isolation & purification; D003437:Crotonates; D006801:Humans; D006885:Hydroxybutyrates / Q000097:blood; D007555:Isoxazoles / Q000378:metabolism / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000188:drug therapy* / Q000821:virology; D016030:Kidney Transplantation; D000077339:Leflunomide; D009570:Nitriles; D027601:Polyomavirus Infections / Q000188:drug therapy*; D014052:Toluidines; D014412:Tumor Virus Infections / Q000188:drug therapy*
D000814:Aniline Compounds; D000998:Antiviral Agents; D003437:Crotonates; D006885:Hydroxybutyrates; D007555:Isoxazoles; D009570:Nitriles; D014052:Toluidines; C527525:teriflunomide; D000077339:Leflunomide